1.40
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt ESPR?
Forum
Prognose
Aktiensplit
Esperion Therapeutics Inc Aktie (ESPR) Neueste Nachrichten
What is the dividend policy of Esperion Therapeutics Inc. stockInvest smarter with data-backed trading alerts - jammulinksnews.com
Is Esperion Therapeutics Inc. a good long term investmentStay ahead with advanced stock screening tools - jammulinksnews.com
Esperion Therapeutics Inc. Stock Analysis and ForecastCapitalize on stocks with high profit margins - jammulinksnews.com
What are Esperion Therapeutics Inc. company’s key revenue driversExceptional trading performance - jammulinksnews.com
Is Esperion Therapeutics Inc. stock overvalued or undervaluedExceptional market positioning - jammulinksnews.com
How does Esperion Therapeutics Inc. compare to its industry peersFree Stock Outlook That Work - jammulinksnews.com
Esperion Therapeutics soars amid vague takeover speculation - MSN
Is Esperion Therapeutics Inc. a growth stock or a value stockBeginner Investor Opportunities To Watch Now - jammulinksnews.com
What is the risk reward ratio of investing in Esperion Therapeutics Inc. stockRetirement Planning Report With Low Risk - jammulinksnews.com
Should I hold or sell Esperion Therapeutics Inc. stock in 2025Wealth Building Review That Work - jammulinksnews.com
What are the latest earnings results for Esperion Therapeutics Inc.Free Stock Alerts For Every Investor - jammulinksnews.com
What institutional investors are buying Esperion Therapeutics Inc. stockReal Time Watchlist With Proven Results - jammulinksnews.com
Is Esperion Therapeutics Inc. a Top Dividend Stock to Watch in 2025Investment Strategy With Predictable Gains Outlined - metal.it
Analysts Estimate Esperion Therapeutics (ESPR) to Report a Decline in Earnings: What to Look Out for - Yahoo Finance
Esperion Therapeutics (ESPR) Gets Boost from Acquisition Rumors - MSN
What makes Esperion Therapeutics Inc. stock price move sharplyMarket Entry and Exit Point Tips From Traders - metal.it
How many analysts rate Esperion Therapeutics Inc. as a “Buy”Expert guidance for superior capital growth - jammulinksnews.com
Is Esperion Therapeutics Inc. a Top Dividend Stock to Watch in 2025 Profit Target Planning with Exit Confidence - metal.it
Why is Esperion Therapeutics Inc. stock attracting strong analyst attentionRapidly growing investment returns - jammulinksnews.com
How strong is Esperion Therapeutics Inc. company’s balance sheetUnlock powerful portfolio management tools - jammulinksnews.com
What analysts say about Esperion Therapeutics Inc. stockFree Predictions - PrintWeekIndia
Esperion Therapeutics Shares Surge 19% Amid Rumors - AInvest
Is Esperion Therapeutics Inc. stock a good hedge against inflationFree Popular Stock Recommendations - jammulinksnews.com
Esperion Therapeutics Surges: Can This Momentum Last? - StocksToTrade
Esperion Therapeutics soars amid vague takeover speculation (ESPR:NASDAQ) - Seeking Alpha
Esperion Therapeutics to Release Q2 2025 Financial Results and Host Webcast on August 5 - AInvest
Esperion to Announce Second Quarter 2025 Financial Results on August 5, 2025 - Quiver Quantitative
Esperion to Report Second Quarter 2025 Financial Results on August 5 - The Manila Times
What drives Esperion Therapeutics Inc. stock priceUnstoppable profit momentum - jammulinksnews.com
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):